Neovia Oncology Ltd. logo

Neovia Oncology Ltd.

Neovia develops oncology drugs that may enhance immunotherapy response to overcome drug resistance and has begun a Phase 1 clinical trial designed to evaluate our lead multi-inhibitor, (NEV-801), that has the potential to treat patients with advanced drug-resistant cancers as monotherapy, or in combination with immunotherapy.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://www.neoviaoncology.com
Founded2011
Disease Focus
Development Stage
STOCK CODENon Listed
Address
10900 Northeast 4th Street
Bellevue
United States
Email
Contact Number
+1 425-298-4099

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=” ” connections=”true” suffix=””]